SLC7A11 and neoplasm: The combination of the anti-inflammatory drug ibuprofen and the SLC7A11 inhibitor SASP with chemotherapy showed better efficacy, with obvious growth delay of 3-methylcholanthrene (3-MCA) sarcoma, decreased tumour volume, and improved survival rate in mice [103].